Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Antonaci

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Immunopharmacology and Immunotoxicology|November 7, 1998
Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A reviewS Antonaci, O Schiraldi
Diagnostic and Clinical Immunology|January 1, 1987
Immunoregulation in agingS Antonaci, E Jirillo, L Bonomo
Immunopharmacology and Immunotoxicology|January 17, 2002
Neutrophil oxidative metabolism in aged humans: a perspectiveC Tortorella, G Piazzolla, S Antonaci
Archives of Gerontology and Geriatrics|January 1, 1992
Neuroimmune networks and aging of the immune system: biological and clinical significanceV Covelli, E Jirillo, S Antonaci
Bollettino Dell'Istituto Sieroterapico Milanese|September 30, 1983
Effects of prostaglandin E2 on immunoglobulin synthesisE Jirillo, S Antonaci, L Bonomo
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1975
Two-dimensional immunolectrophoresis as a diagnostic tool for heavy chain diseaseF Dammacco, S Antonaci, A Miglietta
Minerva Medica|July 14, 1975
[Amyloidosis. Immunochemical study]F Dammacco, S Antonaci, G Lucivero
British Journal of Haematology|June 1, 1983
Philadelphia chromosome-positive pre-B cell acute leukaemia in an adult woman: early lymphoid blast crisis of chronic myeloid leukaemia?G Lucivero, S Antonaci, L Bonomo
Immunopharmacology and Immunotoxicology|December 10, 1999
Soluble HLA class I antigens in chronic hepatitis C: a disease-associated manifestation or molecules modulating immunoresponsiveness?S Antonaci, E Jirillo, O Schiraldi
Current Pharmaceutical Design|November 30, 2007
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinomaG Giannelli, N Napoli, S Antonaci
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Immunopharmacology and Immunotoxicology|November 7, 1998
Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A reviewS Antonaci, O Schiraldi
Diagnostic and Clinical Immunology|January 1, 1987
Immunoregulation in agingS Antonaci, E Jirillo, L Bonomo
Immunopharmacology and Immunotoxicology|January 17, 2002
Neutrophil oxidative metabolism in aged humans: a perspectiveC Tortorella, G Piazzolla, S Antonaci
Archives of Gerontology and Geriatrics|January 1, 1992
Neuroimmune networks and aging of the immune system: biological and clinical significanceV Covelli, E Jirillo, S Antonaci
Bollettino Dell'Istituto Sieroterapico Milanese|September 30, 1983
Effects of prostaglandin E2 on immunoglobulin synthesisE Jirillo, S Antonaci, L Bonomo
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1975
Two-dimensional immunolectrophoresis as a diagnostic tool for heavy chain diseaseF Dammacco, S Antonaci, A Miglietta
Minerva Medica|July 14, 1975
[Amyloidosis. Immunochemical study]F Dammacco, S Antonaci, G Lucivero
British Journal of Haematology|June 1, 1983
Philadelphia chromosome-positive pre-B cell acute leukaemia in an adult woman: early lymphoid blast crisis of chronic myeloid leukaemia?G Lucivero, S Antonaci, L Bonomo
Immunopharmacology and Immunotoxicology|December 10, 1999
Soluble HLA class I antigens in chronic hepatitis C: a disease-associated manifestation or molecules modulating immunoresponsiveness?S Antonaci, E Jirillo, O Schiraldi
Current Pharmaceutical Design|November 30, 2007
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinomaG Giannelli, N Napoli, S Antonaci
Pageof 15